Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John Nolan
Observed names:
J Nolan,
J. Nolan,
J.C. Nolan,
John C. Nolan
Institution:
Ollscoil na Gaillimhe – University of Galway
Observed institutions:
Royal College of Surgeons in Ireland,
Ollscoil na Gaillimhe – University of Galway,
University of Exeter,
Mount Vernon Hospital,
University of Manchester,
Children's Health Ireland at Crumlin,
National Children’s Research Centre,
Medical Research Council
show all 8
ORCID:
0000-0003-4877-7647
Observed ORCID:
0000-0003-4877-7647
OpenAlex ID:
A5026348229
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
2002
·
Peter D Davis
, Graeme J Dougherty
, et al.
·
PubMed
·
244
The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro
2015
·
Olga Piskareva
, Harry Harvey
, et al.
·
Cancer Letters
·
101
A physiologically relevant 3D collagen-based scaffold–neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models
2018
·
C. Curtin
, J.C. Nolan
, et al.
·
Acta Biomaterialia
·
77
PDF
Indolequinone Antitumor Agents: Reductive Activation and Elimination from (5-Methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl Derivatives and Hypoxia-Selective Cytotoxicity in Vitro
1998
·
Matthew A. Naylor
, Elizabeth Swann
, et al.
·
Journal of Medicinal Chemistry
·
75
Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine
1988
·
IJ Stratford
, GE Adams
, et al.
·
British Journal of Cancer
·
60
PDF
2-Cyclopropylindoloquinones and Their Analogues as Bioreductively Activated Antitumor Agents: Structure−Activity in Vitro and Efficacy in Vivo
1997
·
Matthew A. Naylor
, Mohammed Jaffar
, et al.
·
Journal of Medicinal Chemistry
·
56
The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions
2000
·
Mark P Saunders
, Mohammed Jaffar
, et al.
·
Biochemical Pharmacology
·
45
A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitro
2020
·
John C. Nolan
, Manuela Salvucci
, et al.
·
Frontiers in Cell and Developmental Biology
·
32
Endogenous exosome labelling with an amphiphilic NIR-fluorescent probe
2018
·
Marco P. Monopoli
, Andrea Zendrini
, et al.
·
Chemical Communications
·
30
NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole
1990
·
LM Cobb
, T Hacker
, et al.
·
British Journal of Cancer
·
27
PDF
Distribution of pimonidazole and RSU 1069 in tumour and normal tissues
1990
·
LM Cobb
, J Nolan
, et al.
·
British Journal of Cancer
·
24
PDF
Retention of misonidazole in normal and malignant tissues: Interplay of hypoxia and reductases
1992
·
Leon M. Cobb
, F.R.C. Path
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
22
PDF
Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse
1990
·
Leon M. Cobb
, John Nolan
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
22
Prodrugs for targeting hypoxic tissues: Regiospecific elimination of aspirin from reduced indolequinones
1999
·
M Jaffar
, S.A Everett
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
21
Microscopic distribution of misonidazole in mouse tissues
1989
·
LM Cobb
, J Nolan
, et al.
·
British Journal of Cancer
·
19
PDF
Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice
1991
·
S. Cole
, I.J. Stratford
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
17
Autoradiographic study of tritium-labeled misonidazole in the mouse
1989
·
Leon M. Cobb
, F.R.C. Path
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
15
Indolequinone bioreductive drugs: kinetic factors which influence selectivity for hypoxia.
1998
·
S A Everett
, M A Naylor
, et al.
·
PubMed
·
12
Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients
2021
·
Bénédicte Brulin
, John C. Nolan
, et al.
·
Cancers
·
11
PDF
Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity
1994
·
Matthew A. Naylor
, Bridget M. Sutton
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
7
Assessment of Basic Biological Functions Exerted by miRNAs
2016
·
John Nolan
, Raymond L. Stallings
, et al.
·
Methods in molecular biology
·
5
ChemInform Abstract: Prodrugs for Targeting Hypoxic Tissues: Regiospecific Elimination of Aspirin from Reduced Indolequinones.
1999
·
M. Jaffar
, S. A. Everett
, et al.
·
ChemInform
Show more works
View as search
Works count:
22
Citation count:
922
H-index:
16
I10-index:
19
Year
Topic
Type